J
Jamie Shaw
Researcher at University of Manitoba
Publications - 3
Citations - 178
Jamie Shaw is an academic researcher from University of Manitoba. The author has contributed to research in topics: Internal medicine & Antigen. The author has an hindex of 2, co-authored 3 publications receiving 84 citations.
Papers
More filters
Journal ArticleDOI
HLA‐DR/DQ molecular mismatch: A prognostic biomarker for primary alloimmunity
Chris Wiebe,Vasilis Kosmoliaptsis,Denise Pochinco,Ian W. Gibson,Julie Ho,Patricia E. Birk,Aviva Goldberg,Martin Karpinski,Jamie Shaw,David N. Rush,Peter Nickerson +10 more
TL;DR: HLA‐DR/DQ single molecule eplet mismatch may represent a precise, reproducible, and widely available prognostic biomarker that can be applied to tailor immunosuppression or design clinical trials based on individual patient risk.
Journal ArticleDOI
Evidence for the alloimmune basis and prognostic significance of Borderline T cell-mediated rejection.
Chris Wiebe,David N. Rush,Ian W. Gibson,Denise Pochinco,Patricia E. Birk,Aviva Goldberg,Tom Blydt-Hansen,Martin Karpinski,Jamie Shaw,Julie Ho,Peter Nickerson +10 more
TL;DR: The correlation of HLA‐DR/DQ molecular mismatch category with TCMR, including Borderline, provides evidence for their alloimmune basis and can be applied to tailor immunosuppression or design clinical trials based on individual patient risk.
Journal ArticleDOI
The negative impact of T cell-mediated rejection on renal allograft survival in the modern era.
Christie Rampersad,Robert Balshaw,Ian W. Gibson,Julie Ho,Jamie Shaw,Martin Karpinski,Aviva Goldberg,Patricia E. Birk,David N. Rush,Peter Nickerson,Chris Wiebe +10 more
TL;DR: The prevalence and long-term impact of T cell-mediated rejection (TCMR) is poorly defined in the modern era of tacrolimus/mycophenolate-based maintenance therapy as mentioned in this paper.